Prexton Therapeutics

Prexton has the objective to develop novel small molecules on mGluR4 as new treatment for Parkinson’s disease.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Champel, Geneva, GE, Switzerland
  • Currency USD
  • Founded July 2012
  • Employees 4
  • Website prextontherapeutics.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free